Background Analysis: US FDA Advisory Committee to Review Paratek’s Omadacycline for Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin Structure Infections Report
Background Analysis: US FDA Advisory Committee to Review Paratek’s Omadacycline for Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin Structure Infections Report